Post by Michael J. Bojdys

Director BioBlock | Founder MANA.energy | Guestprofessor at Humboldt-Universität zu Berlin | @bojdysLAB | #ERCfunded | #WEFscientists @wef | Genshagener Kreis e.V.

Magdalena Skipper’s post lands close to a conversation I had two weeks ago at with Francesco Matteucci, Margit Kuuse, Tobias Szarowicz, Philipp Adelhelm, and Hans Hennig von Grünberg about why Europe struggles to move strong science into validated technologies and industrial uptake. The SCORE results quantify what sits at the heart of the “reproducibility crisis” of R&D results: if half of tested claims don’t replicate, then stage-gated progression without shared evidence standards is just bureaucracy. The gates have to test something real. Two points stood out: (1) The “three Rs” are real acceptance criteria for technology transfer decisions. A milestone that cannot be independently verified is not a milestone. (2) Data accessibility is a must. SCORE confirms what we see in deep-tech consortia: you cannot test what you cannot access. That is the infrastructure problem DATIpilot BioBlock Innovationscommunity (our 27-partnerBMFTR consortium) is built to solve: a FAIR data architecture so that evidence is structurally available for verification. Hans-Hennig von Grünberg’s provocation at CIC Berlin “Do not write papers” is important here: if academia overly rewards publication while under-rewarding replicated prototypes and validated artefacts, the replication crisis will persist as an outcome of false incentives. Günter M. Ziegler Fatma Deniz Julia von Blumenthal Arnost Marks Stefan Hecht Ruth Morgan Martin Rahmel Maria Ksenia Witte #ReplicationCrisis #DeepTech #InnovationGovernance #FAIR #TechTransfer #OpenScience

Post content